Transcriptomic analysis reveals distinct adaptive molecular mechanism in the hippocampal CA3 from rats susceptible or not-susceptible to hyperthermia-induced seizures
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PORTFOLIO
Autores
TAKAHARA, Andre K.
KHALED, Nathalia A.
SANTOS, Paula
CESAR, Roberto M.
Citação
SCIENTIFIC REPORTS, v.13, n.1, 2023
Resumo
Febrile seizures during early childhood are a relevant risk factor for the development of mesial temporal lobe epilepsy. Nevertheless, the molecular mechanism induced by febrile seizures that render the brain susceptible or not-susceptible to epileptogenesis remain poorly understood. Because the temporal investigation of such mechanisms in human patients is impossible, rat models of hyperthermia-induced febrile seizures have been used for that purpose. Here we conducted a temporal analysis of the transcriptomic and microRNA changes in the ventral CA3 of rats that develop (HS group) or not-develop (HNS group) seizures after hyperthermic insult on the eleventh postnatal day. The selected time intervals corresponded to acute, latent, and chronic phases of the disease. We found that the transcriptional differences between the HS and the HNS groups are related to inflammatory pathways, immune response, neurogenesis, and dendritogenesis in the latent and chronic phases. Additionally, the HNS group expressed a greater number of miRNAs (some abundantly expressed) as compared to the HS group. These results indicate that HNS rats were able to modulate their inflammatory response after insult, thus presenting better tissue repair and re-adaptation. Potential therapeutic targets, including genes, miRNAs and signaling pathways involved in epileptogenesis were identified.
Palavras-chave
Referências
- Ahmad S, 2010, SEMIN PEDIATR NEUROL, V17, P150, DOI 10.1016/j.spen.2010.06.004
- Atkin G, 2014, J BIOL CHEM, V289, P7038, DOI 10.1074/jbc.M113.515056
- Azevedo H, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029074
- Bando SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026268
- Bando SY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89802-3
- Bando SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079913
- Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
- Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3
- Baulac M, 2015, REV NEUROL-FRANCE, V171, P259, DOI 10.1016/j.neurol.2015.02.004
- Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7
- Bender RA, 2004, ADV EXP MED BIOL, V548, P213
- Bender RA, 2003, HIPPOCAMPUS, V13, P399, DOI 10.1002/hipo.10089
- Borghi R, 2021, J CLIN MED, V10, DOI 10.3390/jcm10132754
- Brennan GP, 2020, NAT REV NEUROL, V16, P506, DOI 10.1038/s41582-020-0369-8
- Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042
- Butler KM, 2018, BRAIN, V141, P2392, DOI 10.1093/brain/awy171
- Canto AM, 2021, HIPPOCAMPUS, V31, P122, DOI 10.1002/hipo.23268
- Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
- Colmers William F., 2003, Epilepsy Curr, V3, P53, DOI 10.1046/j.1535-7597.2003.03208.x
- Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018
- Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.3.CO;2-N
- Dube C. M., 2012, JASPERS BASIC MECH E
- Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010
- Dube CM, 2009, EXP NEUROL, V215, P167, DOI 10.1016/j.expneurol.2008.10.003
- El Ghaleb Y, 2021, BRAIN, V144, P2092, DOI 10.1093/brain/awab101
- Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410
- Feng Y, 2022, SEIZURE-EUR J EPILEP, V101, P22, DOI 10.1016/j.seizure.2022.07.007
- Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163
- Ghafouri-Fard S, 2022, MOL BIOL REP, V49, P5057, DOI 10.1007/s11033-022-07188-5
- Giovedi S, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00094
- Gonzalez-Calvo I, 2021, ELIFE, V10, DOI 10.7554/eLife.65712
- Gonzalez-Ramirez M, 2009, SEIZURE-EUR J EPILEP, V18, P533, DOI 10.1016/j.seizure.2009.04.011
- Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006
- Hishimoto A, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0475-2
- Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047
- Jin Y, 2016, BIOL RES, V49, DOI 10.1186/s40659-015-0060-5
- Kessi M, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01850-0
- Kirbach BB, 2011, J NEUROSCI RES, V89, P162, DOI 10.1002/jnr.22536
- Kopczynska M, 2018, SEIZURE-EUR J EPILEP, V60, P1, DOI 10.1016/j.seizure.2018.05.016
- Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
- Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
- Lemmens EMP, 2005, EPILEPSIA, V46, P1603, DOI 10.1111/j.1528-1167.2005.00252.x
- Marek KW, 2010, NAT NEUROSCI, V13, P944, DOI 10.1038/nn.2582
- McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032
- Mo J, 2015, J NEUROCHEM, V133, P489, DOI 10.1111/jnc.13077
- Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3
- Monterrat C, 2006, BBA-MOL CELL RES, V1763, P73, DOI 10.1016/j.bbamcr.2005.11.008
- Moreira CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128174
- NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0
- Oh S. June, 2018, Genomics & Informatics, V16, P2, DOI 10.5808/GI.2018.16.1.2
- Patterson KP, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0034-15.2015
- Patterson KP, 2014, NEUROTHERAPEUTICS, V11, P242, DOI 10.1007/s13311-014-0263-4
- R Core Team, 2020, R LANG ENV STAT COMP
- Raijmakers M, 2016, EPILEPSIA, V57, P717, DOI 10.1111/epi.13357
- Restrepo S, 2019, J NEUROSCI, V39, P9065, DOI 10.1523/JNEUROSCI.1261-19.2019
- Riise J, 2015, J NEURAL TRANSM, V122, P1303, DOI 10.1007/s00702-015-1375-7
- Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
- Sanz P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114096
- Schubert KO, 2012, MOL PSYCHIATR, V17, P669, DOI 10.1038/mp.2011.123
- Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
- Sugaya Y, 2022, FRONT NEURAL CIRCUIT, V15, DOI 10.3389/fncir.2021.781113
- Sun HW, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.844141
- Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962
- Sun WY, 2020, MOL NEUROBIOL, V57, P5044, DOI 10.1007/s12035-020-02069-z
- Toyoda I, 2013, J NEUROSCI, V33, P11100, DOI 10.1523/JNEUROSCI.0472-13.2013
- van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139
- Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086
- Vezzani A, 2019, NAT REV NEUROL, V15, P459, DOI 10.1038/s41582-019-0217-x
- Wang W, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.3
- Wang YS, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.596709
- Wu CP, 2005, NEUROSCIENCE, V130, P527, DOI 10.1016/j.neuroscience.2004.09.041
- Wu D, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm3381
- Wu L, 2018, NEUROCHEM RES, V43, P1269, DOI 10.1007/s11064-018-2544-5
- Wu XN, 2020, NEUROSCIENTIST, V26, P9, DOI 10.1177/1073858419844497
- Yepes M, 2019, CURR DRUG TARGETS, V20, P953, DOI 10.2174/1389450120666181211144550
- Yu Y, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101682
- ZHAO DY, 1985, EXP NEUROL, V88, P688, DOI 10.1016/0014-4886(85)90080-9
- Zhu HX, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11172621